Carlson Capital’s Intersect ENT, Inc XENT Stock Holding History

Carlson Capital’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-155,000	Closed	-$4.34M	–	188
2022 Q1	$4.34M	Buy	+155,000	New	+$4.25M	0.3%	89
2015 Q3	–	Sell	-104,831	Closed	-$3M	–	355
2015 Q2	$3M	Buy	+104,831	New	+$2.75M	0.03%	264

Carlson Capital's XENT Position: Q2 2022 in Review

Carlson Capital sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 155,000 shares — an estimated $4.34M sold.

Carlson Capital first reported a position in XENT in Q2 2015 and held it in 2 quarters. The position peaked at $4.34M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Carlson Capital reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Carlson Capital sold 155,000 Intersect ENT, Inc shares in Q2 2022, an estimated $4.34M.
Carlson Capital first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 2 quarters.
Carlson Capital's Intersect ENT, Inc position peaked at $4.34M in Q1 2022.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Carlson Capital's 13F filing for Q2 2022, filed 15 Aug 2022.